Hints and tips:
Related Special Reports
...He said the access to UK and EU markets was an “absolutely key advantage” for the region....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...to equitable access to drugs and vaccines....
...Caparra was able to secure supplies for her son with the support of a non-profit organisation, Angels for Change, that focuses on drug access....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...The National Institute for Health and Care Excellence announced on Tuesday that it would not approve the medication Enhertu, developed by pharmaceutical companies Daiichi Sankyo and AstraZeneca, to treat...
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...Paxlovid — designed to be given to patients shortly after they test positive for the virus — has been far easier to obtain in the US than in Europe, where access has often been restricted to the elderly...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...Increasing awareness and access are key to rebuilding vaccine coverage. UK polling in 2022 found more than 90 per cent of parents of young children believed vaccines worked and were safe....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...The decision is the latest twist in legal wrangling between anti-abortion campaigners, the Biden administration and the pharmaceutical industry over the regulatory standing of mifepristone....
...Turns out the portfolio goes up and down a lot more . . . . . . where the main beneficiaries are going to be investors with access to a time machine: This is Citi’s third note to clients since October...
...Friday’s decision comes after the state of New Hampshire failed in its bid to receive FDA permission because it did not identify a pharmaceutical wholesaler which could deliver the drugs....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against US pharmacy chains such as CVS and Walgreens. Read more here...
...Young scientists were often “chronically underpaid” and suffered from a lack of mentoring and access to grants, said Belkaid, adding that many dropped out to pursue better-paid careers elsewhere....
...Orchard, a UK-based biotech that was recently bought by Japanese pharmaceutical group Kyowa Kirin, argued that the lack of other treatments for MLD justified the price....
...She used to be able to go to a hospital in the West Bank, but since the start of the war, she has been trapped in Gaza with no access to medication....
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...Installing updates, replacing old devices, ensuring the ability to erase data from devices and protecting physical access to devices were among the other recommendations made by the NCSC....
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
...A big database of potential participants would make the country an attractive location for pharma companies to carry out tests, accelerating the UK’s access to medicines and providing potential treatments...
...The current draft does not address this and is thus essentially limited to enabling the manufacture of comparatively simple pharmaceutical products, which generally do not require access to information that...
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
International Edition